IDEXX Laboratories, Inc.

NASDAQ:IDXX

Medical - Diagnostics & Research

Healthcare
$698.47 +2.26%

+$12.33 today

Market cap
$55.03B
Beta
1.54
P/E (TTM)
40.8
EPS (TTM)
$13.67
52W Low $506.91High $769.98

Volume 0.37M

Average 0.58M

IDXX Other Stockholders Equity

Equity items not reported separately, such as additional paid-in capital or treasury stock.

IDEXX Laboratories, Inc.NASDAQ: IDXX

Other Stockholders Equity · Q3 FY2026 · quarter ended Sep 2026

Other stockholders equity rises 29907.7% from a year ago

Other stockholders equity stood at $1.87B at the end of Q3 FY2026, up 29907.7% from a year earlier and up 31378.2% from the prior quarter. Over 3 fiscal years it compounded at +5.6% a year.

Context

  • Other stockholders equity amounted to 50.4% of total assets at the end of Q3 FY2026, up 50.2 pp from a year earlier.
  • Other stockholders equity increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether other stockholders equity keeps rising in the next quarterly balance sheet after a +29907.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterSep 2026
$1.87B+31378.2% QoQ
Last fiscal yearDec 2025
$6.09M+3.6% YoY
Year agoSep 2025
$6.23M+29907.7% since
Other Stockholders Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+29907.7%——
1 year+3.6%——
3-year CAGR+5.6%——
5-year CAGR——
10-year CAGR——

Other Stockholders Equity history

USD · from the balance sheet

Latest · FY2025
6.09M USD
Year-over-year change
+3.6%
4-year CAGR
+1.6%

Other Stockholders Equity vs competitors

How IDXX compares with its peers on the latest reported figures

  • IDXX's Sep 2026 other stockholders equity of $1.87B is the 2nd highest of the 5 companies compared; the peer median is $0.
  • Other stockholders equity amounts to 50.4% of total assets for IDXX, versus a peer median of 0.0%.
IDXX Competitors Peer median
Other Stockholders Equity for IDXX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ELANElanco Animal Health IncorporatedSep 2026$8.9B ——66.7%
IDXXIDEXX Laboratories, Inc.Sep 2026$1.87B +29907.7%+5.6%50.4%
MRKMerck & Co., Inc.Jun 2026$0 ——0.0%
ZTSZoetis Inc.Jun 2026$0 ——0.0%
NEOGNeogen CorporationAug 2026$0 ——0.0%
Peer median (excluding IDXX) $0——0.0%

Competitors are the stored peer set for IDXX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents144.45M112.55M453.93M288.27M180.07M
Short-term Investments00000
Net Receivables425.58M490.9M529.53M561.32M693.19M
Inventory269.03M367.82M380.28M381.88M377.76M
Other Current Assets74.59M88.46M83.14M109.81M31.35M
Total Current Assets955.66M1.1B1.5B1.4B1.34B
Property, Plant & Equipment (Net)692.77M768.09M817.68M829.25M870.61M
Goodwill359.35M361.8M365.96M405.1M414M
Intangible Assets99.04M97.67M84.5M111.68M109.84M
Long-term Investments18.6M55.5M56.19M57.72M297.09M
Tax Assets24.78M55.22M107.36M125.63M27.87M
Other Non-current Assets287.02M307.01M332.98M364.17M291.08M
Total Non-current Assets1.48B1.65B1.76B1.89B2.01B
Total Assets2.44B2.75B3.26B3.29B3.35B
Account Payables116.14M110.22M110.64M114.21M110.41M
Short-term Debt148.5M653.98M325M417.79M500.07M
Tax Payables42.61M48.55M86.55M62.25M0
Deferred Revenue40.03M37.94M37.2M33.8M35.26M
Other Current Liabilities182.93M142.99M174.38M174.58M201.96M
Total Current Liabilities763.58M1.24B951.55M1.07B1.15B
Long-term Debt775.21M694.39M622.88M449.79M475.99M
Deferred Tax Liabilities8.94M8.15M7.24M11.31M31.87M
Deferred Revenue (Non-current)41.17M30.86M28.53M26.94M32.18M
Other Non-current Liabilities70.94M67.59M65.53M44.34M(44.62M)
Total Non-current Liabilities983.63M902.23M823.85M630.21M596.56M
Total Liabilities1.75B2.14B1.78B1.7B1.75B
Common Stock10.69M10.72M10.75M10.78M10.84M
Retained Earnings2.92B3.6B4.44B5.33B6.39B
Accumulated OCI(53.48M)(77.8M)(71.21M)(93.65M)(68.84M)
Other Stockholders Equity5.72M5.18M5.53M5.89M6.09M
Minority Interest00000
Total Equity689.99M608.74M1.48B1.6B1.61B
Total Debt1.03B1.47B1.07B986.95M1.08B
Net Debt886.56M1.36B613.42M698.68M897.14M

IDEXX Laboratories, Inc.

NASDAQ:IDXX

Intrinsic Alpha fair value

Locked

Current Price

$698.47

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.